12th April 2026, Sunday

TechPharus

Latest Posts

HealthTech News

  • A simple shot shows promise to reverse osteoarthritis within weeks
    on April 12, 2026 at 6:30 pm

    A research team including scientists and engineers from University of Colorado Boulder, CU Anschutz and Colorado State University has developed a suite of new therapies that prompt aging or damaged joints to repair themselves within weeks, according to animal studies.

  • As RSV evolves, a two‑pronged antibody cocktail aims to stay ahead
    on April 12, 2026 at 6:00 pm

    Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory studies prevented the virus from developing drug resistance—a persistent problem with current therapies for infants. RSV is a seasonal infection that circulates globally and can be especially dangerous for people at opposite ends of the age spectrum: infants and older adults. Vaccines are available for those who are 65 and older (GlaxoSmithKline’s Arexvy, Pfizer’s ABRYSVO and Moderna’s mRESVIA), but there is still no available vaccine for infants who are among the most vulnerable.

  • Immune cells in the nose slow influenza virus, study finds
    on April 12, 2026 at 5:00 pm

    A new study from the University of Gothenburg may help guide the development of better influenza vaccines. Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce viral levels and may help protect against more severe illness. The findings are published in the Journal of Experimental Medicine.

  • Water contaminated with ‘forever chemicals’ during pregnancy linked to an increased risk of childhood asthma
    on April 12, 2026 at 4:30 pm

    PFAS, or per- and polyfluoroalkyl substances, are a group of human-made chemicals found in everything from food packaging to firefighting foam. Often called “forever chemicals” due to their persistence in the environment, they can affect our health and disrupt our immune system.

  • Nerve growth factor alone triggers osteoarthritis-like joint changes in healthy mice
    on April 12, 2026 at 3:00 pm

    Nerve growth factor (NGF) is a specialized protein, also called a neurotrophin, that is critical for the development and survival of nerves responsible for our senses and the body’s fight-or-flight response. While the presence of NGF is crucial during the embryonic stage, its presence in adults is often an indication of inflammation, as it is a key mediator of pain for conditions like osteoarthritis (OA). Now, a study published in Arthritis & Rheumatology shows that NGF is much more than a pain messenger—it can actually change the structure of a joint.